Home | News | i2C PHARM participation at the DDL2022 conference

i2C PHARM participation at the DDL2022 conference

Dr Chen Zhen represented i2c Pharmaceutical Services, one of our project partners, at the Drug Delivery to the Lungs (DDL2022) Conference that took place in Edinburgh from December 7th to December 9th.

This annual event, which combines face-to-face and virtual attendance, is an industry exhibition focused on respiratory and nasal drug delivery.  It gathers professionals with a multidisciplinary approach including scientists, academics, clinicians, regulators and industry experts to share their scientific advances in respiratory health.

The contributions from the Light4Lungs project were included in the agenda in this edition of the conference, with a presentation from Dr Chen Zheng: ”A Method for Evaluation of Aerodynamic Particle Size Distribution of Novel Inhalable Light Emitting Particles for Photodynamic Therapy – Light4Lungs.” He shared i2C Pharma’s work regarding aerosolization in the scope of our project.

Download the paper:

A Method for Evaluation of Aerodynamic Particle Size Distribution of Novel Inhalable Light Emitting Particles for Photodynamic Therapy – Light4Lungs

Learn more about this annual event:

DDL2022 conference website